Nugen technologies, INC.:1164879 [14-057222]
Ended Awarded Last action
- Contract number
- HHSN26100001
- Awardee
-
Tecan Genomics, Inc. UEI R4DEKMG6K8N4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,541
Award facts
- Contract value 100% obligated
- $7,541.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$50 | |
| Original award | $7,591 |
About this award
The National Cancer Institute (NCI) awarded a Firm Fixed Price BPA call valued at $7,541.00 to Tecan Genomics, Inc. on August 19, 2014, with an ultimate completion date of September 18, 2014. This contract was performed in Bethesda, Maryland and utilized no set-aside designation. Tecan Genomics, a Switzerland-based manufacturer specializing in life science laboratory automation and genomic research technologies, provided scientific research products and equipment to support NCI's research initiatives.
This award was issued as a call against Tecan Genomics' existing Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations, a single-award indefinite delivery vehicle valued at $100 million through March 31, 2025. The BPA enables the company to supply a comprehensive range of biological materials and research products, including RNA sequencing kits, genomic analysis systems, and specialized reagents to support infectious disease, genomics, and other critical research programs across the National Institutes of Health and federal scientific agencies. The relatively modest call value represents a discrete procurement action for specific research materials or equipment needed to support NCI's ongoing scientific research efforts.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to Tecan Genomics, Inc. by National Cancer Institute (National Institutes of Health) on August 19, 2014.
How much is contract HHSN26100001 worth?
The government has obligated $7,541 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263201300006B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award